NRX Pharmaceuticals, Inc. (NRXP)
2.71
+0.12
(+4.63%)
USD |
NASDAQ |
Oct 15, 15:42
NRX Pharmaceuticals Gross Profit Margin (Quarterly) : 23.43% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.43% |
| March 31, 2026 | 25.47% |
| Date | Value |
|---|---|
| December 31, 2025 | 48.32% |
| September 30, 2025 | 42.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 73.00% |
| Eli Lilly & Co. | 85.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -148.9% |
| Profit Margin (Quarterly) | -1.50K% |
| Operating Margin (Quarterly) | -590.5% |
| Return on Net Operating Assets | -530.5% |